Christopher K. Payne, MD

Publications

• Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. Fitzgerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O'Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM. J Urol. 2013; 189 (1 Suppl): S75-85
• Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. Forrest JB, Payne CK, Erickson DR. J Urol. 2012; 188 (4): 1186-91
• Interstitial cystitis and the overlap with overactive bladder. Elliott CS, Payne CK. Curr Urol Rep. 2012; 13 (5): 319-26
• Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. FitzGerald MP, Payne CK, Lukacz ES, Yang CC, Peters KM, Chai TC, Nickel JC, Hanno PM, Kreder KJ, Burks DA, Mayer R, Kotarinos R, Fortman C, Allen TM, Fraser L, Mason-Cover M, Furey C, Odabachian L, Sanfield A, Chu J, Huestis K, Tata GE, Dugan N, Sheth H, Bewyer K, Anaeme A, Newton K, Featherstone W, Halle-Podell R, Cen L, Landis JR, Propert KJ, Foster HE, Kusek JW, Nyberg LM. J Urol. 2012; 187 (6): 2113-8
• Robot-assisted versus open sacrocolpopexy: a cost-minimization analysis. Elliott CS, Hsieh MH, Sokol ER, Comiter CV, Payne CK, Chen B. J Urol. 2012; 187 (2): 638-43
• Urologic chronic pelvic pain. Potts JM, Payne CK. Pain. 2012; 153 (4): 755-8
• AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, Forrest JB, Gordon B, Gray M, Mayer RD, Newman D, Nyberg L, Payne CK, Wesselmann U, Faraday MM. J Urol. 2011; 185 (6): 2162-70
• Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned. Yang CC, Burks DA, Propert KJ, Mayer RD, Peters KM, Nickel JC, Payne CK, FitzGerald MP, Hanno PM, Chai TC, Kreder KJ, Lukacz ES, Foster HE, Cen L, Landis JR, Kusek JW, Nyberg LM. J Urol. 2011; 185 (3): 901-6
• Treatment choice, duration, and cost in patients with interstitial cystitis and painful bladder syndrome. Anger JT, Zabihi N, Clemens JQ, Payne CK, Saigal CS, Rodriguez LV. Int Urogynecol J. 2011; 22 (4): 395-400
• Effect of amitriptyline on symptoms in treatment naïve patients with interstitial cystitis/painful bladder syndrome. Foster HE, Hanno PM, Nickel JC, Payne CK, Mayer RD, Burks DA, Yang CC, Chai TC, Kreder KJ, Peters KM, Lukacz ES, FitzGerald MP, Cen L, Landis JR, Propert KJ, Yang W, Kusek JW, Nyberg LM. J Urol. 2010; 183 (5): 1853-8
• Mechanisms of pelvic floor muscle function and the effect on the urethra during a cough. Lovegrove Jones RC, Peng Q, Stokes M, Humphrey VF, Payne C, Constantinou CE. Eur Urol. 2010; 57 (6): 1101-10
• Reply to Peter E.P. Petros' Letter to the Editor re: Ruth C. Lovegrove Jones, Qiyu Peng, Maria Stokes, Victor F. Humphrey, Christopher Payne, Christos E. Constantinou. Mechanisms of Pelvic Floor Muscle Function and the Effect on the Urethra During a Cough. Eur Urol 2010;57:1101-10. Jones RL, Peng Q, Stokes M, Humphrey V, Payne C, Constantinou C. Eur Urol. 2010
• Urodynamics for the evaluation of painful bladder syndrome/interstitial cystitis. Payne C, J Urol. 2010; 184 (1): 15-6
• Epidural steroid injections in the management of a patient with spinal stenosis and urinary urgency. Mitra R, Huang L, Payne C. Nat Clin Pract Urol. 2009; 6 (2): 113-5
• Goal achievement provides new insights into interstitial cystitis/painful bladder syndrome symptoms and outcomes. Payne C, Allee T. Neurourol Urodyn. 2009; 28 (1): 13-7
• Laparoscopic management of ureteral endometriosis: the Stanford University hospital experience with 96 consecutive cases. Bosev D, Nicoll LM, Bhagan L, Lemyre M, Payne CK, Gill H, Nezhat C. J Urol. 2009; 182 (6): 2748-52
• Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. FitzGerald MP, Anderson RU, Potts J, Payne CK, Peters KM, Clemens JQ, Kotarinos R, Fraser L, Cosby A, Fortman C, Neville C, Badillo S, Odabachian L, Sanfield A, O'Dougherty B, Halle-Podell R, Cen L, Chuai S, Landis JR, Mickelberg K, Barrell T, Kusek JW, Nyberg LM. J Urol. 2009; 182 (2): 570-80
• The relationship among symptoms, sleep disturbances and quality of life in patients with interstitial cystitis. Nickel JC, Payne CK, Forrest J, Parsons CL, Wan GJ, Xiao X. J Urol. 2009; 181 (6): 2555-61
• Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. Propert KJ, Mayer R, Nickel JC, Payne CK, Peters KM, Teal V, Burks D, Kusek JW, Nyberg LM, Foster HE. J Urol. 2008; 179 (2): 552-5
• Office dilation of the female urethra: a quality of care problem in the field of urology. Santucci RA, Payne CK, Anger JT, Saigal CS. J Urol. 2008; 180 (5): 2068-75
• Bladder necrosis following hydrodistention in patients with interstitial cystitis. Zabihi N, Allee T, Maher MG, Mourtzinos A, Raz S, Payne CK, Rodríguez LV. J Urol. 2007; 177 (1): 149-52; discussion 152
• Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin? Propert KJ, Mayer R, Nickel JC, Payne CK, Peters KM, Teal V, Burks D, Kusek JW, Nyberg LM, Foster HE. J Urol. 2007; 178 (3 Pt 1): 886-90
• Interstitial cystitis and painful bladder syndrome. Payne CK, Joyce GF, Wise M, Clemens JQ. J Urol. 2007; 177 (6): 2042-9
• Prospective evaluation of candidate urine and cell markers in patients with interstitial cystitis enrolled in a randomized clinical trial of Bacillus Calmette Guerin (BCG). Keay S, Reeder JE, Koch K, Zhang CO, Grkovic D, Peters K, Zhang Y, Kusek JW, Nyberg LM, Payne CK, Propert KJ. World J Urol. 2007; 25 (5): 499-504
• Redefining response in overactive bladder syndrome. Payne CK, Kelleher C. BJU Int. 2007; 99 (1): 101-6
• Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis. Nickel JC, Tripp D, Teal V, Propert KJ, Burks D, Foster HE, Hanno P, Mayer R, Payne CK, Peters KM, Kusek JW, Nyberg LM. J Urol. 2007; 177 (5): 1832-6
• Solifenacin in overactive bladder syndrome. Payne CK, Drugs. 2006; 66 (2): 175-90
• Synchronous rectovaginal, urinary bladder, and pulmonary endometriosis. Hilaris GE, Payne CK, Osias J, Cannon W, Nezhat CR. JSLS. 2005 Jan-Mar; 9 (1): 78-82
• A randomized controlled trial of intravesical bacillus calmette-guerin for treatment refractory interstitial cystitis. Mayer R, Propert KJ, Peters KM, Payne CK, Zhang Y, Burks D, Culkin DJ, Diokno A, Hanno P, Landis JR, Madigan R, Messing EM, Nickel JC, Sant GR, Warren J, Wein AJ, Kusek JW, Nyberg LM, Foster HE. J Urol. 2005; 173 (4): 1186-91
• Correlation between 2 interstitial cystitis symptom instruments. Sirinian E, Azevedo K, Payne CK. J Urol. 2005; 173 (3): 835-40
• Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. Payne CK, Mosbaugh PG, Forrest JB, Evans RJ, Whitmore KE, Antoci JP, Perez-Marrero R, Jacoby K, Diokno AC, O'Reilly KJ, Griebling TL, Vasavada SP, Yu AS, Frumkin LR. J Urol. 2005; 173 (5): 1590-4
• Office bladder distention with electromotive drug administration (EMDA) is equivalent to distention under general anesthesia (GA). Rose AE, Azevedo KJ, Payne CK. BMC Urol. 2005: 5 14
• Pilot study of the feasibility of in-office bladder distention using electromotive drug adminstration (EMDA). Rose AE, Payne CK, Azevedo K. Neurourol Urodyn. 2005; 24 (3): 254-60
• The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Coyne KS, Payne C, Bhattacharyya SK, Revicki DA, Thompson C, Corey R, Hunt TL. Value Health. 2004 Jul-Aug; 7 (4): 455-63
• A new once-daily formulation of tolterodine provides superior efficacy and is well tolerated in women with overactive bladder. Swift S, Garely A, Dimpfl T, Payne C. Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14 (1): 50-4; discussion 54-5
• Research criteria versus clinical criteria for interstitial cystitis. Payne CK, Terai A, Komatsu K. Int J Urol. 2003: 10 Suppl S7-S10
• Sacral neuromodulation in patients with interstitial cystitis: a multicenter clinical trial. Whitmore KE, Payne CK, Diokno AC, Lukban JC. Int Urogynecol J Pelvic Floor Dysfunct. 2003; 14 (5): 305-8; discussion 308-9
• Pitfalls in the design of clinical trials for interstitial cystitis. Propert KJ, Payne C, Kusek JW, Nyberg LM. Urology. 2002; 60 (5): 742-8
• Correlation of symptoms between 2 instruments among interstitial cystitis patients. Sirinian E, Payne CK. Urology. 2001; 57 (6 Suppl 1): 124-5
• Effect of physiologic levels of urinary potassium on interstitial cystitis symptoms. Payne CK, Sirinian E, Azevedo K. Urology. 2001; 57 (6 Suppl 1): 124
• Safety and efficacy of up to 900 mg/day polysulfate sodium (elmiron) in patients with interstitial cystitis. Nickel JC, Forrest J, Barkin J, Payne C, Mosbaugh P. Urology. 2001; 57 (6 Suppl 1): 122-3
• The psychosocial economic impact of invisible chronic disease: examining the experience of patients with interstitial cystitis. Azevedo K, Payne CK. Urology. 2001; 57 (6 Suppl 1): 118
• Behavioral therapy for overactive bladder. Payne CK, Urology. 2000; 55 (5A Suppl): 3-6; discussion 14-6
• A transvaginal sling procedure with bone anchor fixation. Payne CK, Urol Clin North Am. 1999; 26 (2): 423-30, x
• Biofeedback for community-dwelling individuals with urinary incontinence. Payne CK, Urology. 1998; 51 (2A Suppl): 35-9
• Epidemiology, pathophysiology, and evaluation of urinary incontinence and overactive bladder. Payne CK, Urology. 1998; 51 (2A Suppl): 3-10
• Overactive bladder. Payne CK, Urology. 1998; 51 (6): 1062
• The breadth of neurourology. Payne C, J Urol. 1996; 155 (3): 1030-1
• Pressure flow studies for prostatism. Payne CK, Urology. 1995; 45 (3): 552-3
• Genitourinary problems in the elderly patient. Payne CK, Babiarz JW, Raz S. Surg Clin North Am. 1994; 74 (2): 401-29
• Gastrocystoplasty without opening the stomach. Raz S, Ehrlich RM, Babiarz JW, Payne CK. J Urol. 1993; 150 (2 Pt 2): 713-5
• Bladder outlet obstruction treated with transurethral ultrasonic aspiration. One-year follow-up on 59 patients. Malloy TR, Carpiniello VL, Wein AJ, Payne C, Wuchinich D. Urology. 1991; 37 (6): 512-5